Diabetic neuropathy progresses in a recognizable order, and knowing where you are on it tells you what is still recoverable.
Stage 1 — subclinical
Nerve damage is measurable but you feel nothing. Small-fiber testing or nerve conduction studies can be abnormal years before any symptom appears, which is why screening in diabetes exists at all.
This stage is almost entirely reversible with genuine glucose stabilization, and almost nobody is treated in it, because there is nothing to complain about.
Stage 2 — early symptomatic
Burning, tingling, pins and needles or electric sensations, starting in the toes and both feet at once. Characteristically worse at night and worse at rest — which is the opposite of a circulation problem and the single most useful distinguishing feature.
Sensation testing is often still normal at this point. Patients are frequently told nothing is wrong, because the standard examination is not sensitive to small-fiber damage. This is the stage where treatment changes the trajectory most.
Stage 3 — established sensory loss
The burning may actually ease — which patients mistake for improvement and is usually the opposite. Numbness replaces it as the fibers carrying the pain signal die. Loss climbs from the toes toward the ankle in a stocking pattern, and the hands may begin.
Vibration and position sense go, so balance in the dark becomes unreliable. Protective sensation is lost, which is the point at which foot injuries stop being felt and ulcer risk rises sharply.
Stage 4 — motor and complication stage
Weakness appears: difficulty lifting the toes, changes in foot shape as the small muscles waste, clawing of the toes and abnormal pressure points. Balance is measurably impaired and falls become a genuine risk.
This is the stage where foot care stops being advice and becomes essential, because an unnoticed injury on an insensate foot is how amputations begin.
Autonomic damage runs on its own timeline
The nerves controlling heart rate, blood pressure, digestion, sweating and bladder function are damaged in parallel, not afterwards, and the symptoms are rarely connected to diabetes by the patient — dizziness on standing, early fullness after meals, unexplained sweating changes. See autonomic neuropathy.
Why the staging matters
Because it determines the goal. In stages 1 and 2, the goal is reversal and it is realistic — see can diabetic neuropathy be reversed. In stage 3, the goal is pain control and preventing the next stage. In stage 4, the goal is protecting the foot and preventing falls.
Treatment aimed at the wrong stage disappoints. Promising reversal to someone in stage 4 is dishonest; settling for pain control in someone in stage 2 wastes the window.
To be assessed, call (314) 310-5577 or text (314) 886-5902. We are at 12174 Natural Bridge Rd, Suite 110, St. Louis, MO 63044.
Common questions
My burning has gone away. Is that good?
Not necessarily, and it is worth checking. Pain easing as numbness increases usually means the fibers carrying pain have been lost rather than healed.
The mechanism is covered in Prediabetes and Nerve Damage.
How fast does it progress?
Highly variable, and glucose stability is the biggest modifiable factor. It is not a fixed timetable.
That is the subject of Can Diabetic Neuropathy Be Reversed?.
Can you tell me which stage I am in?
Yes — that is largely what the first visit establishes, using examination plus nerve conduction testing where it adds anything.
That is the subject of Diabetic Neuropathy.
Does everyone with diabetes get this?
No. Risk rises with duration and with glucose variability, but a substantial number of people never develop symptomatic neuropathy.
This is set out in Peripheral Neuropathy.
These stages move faster with alcohol than without it.
Sources
- Elafros MA et al. Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments. The Lancet. Neurology, 2022. PubMed 36115364
- Zhu J et al. Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment. Frontiers in endocrinology, 2023. PubMed 38264279
- Ziegler D et al. Neuropathy in prediabetes. Diabetes/metabolism research and reviews, 2023. PubMed 37470302
- Ziegler D. Pathogenetic treatments for diabetic peripheral neuropathy. Diabetes research and clinical practice, 2023. PubMed 38245327
Hurt in an accident? Start here.
You do not need a lawyer, a police report or a referral to be seen. Bring your symptoms and we will work out the rest.
Monday–Friday, 8:00 a.m. – 4:00 p.m. Same-day appointments are often available for new accident and injury patients.